On-Demand Webinars

  1. Where Sourcing Meets Science: Smarter Collaboration, Better Outcomes 4/20/2026

    See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.

  2. Quality By Design For Outsourced Operations 4/16/2026

    A practical guide to applying Quality by Design to outsourced GXP operations, helping virtual and hybrid sponsors maintain regulatory control, inspection readiness, and accountability.

  3. Scalable Strategies For Delivering Value In Clinical Trial Logistics 4/15/2026

    Discover how to transform logistical challenges into strategic advantages with flexible, forward-looking solutions designed for today’s dynamic clinical development landscape.

  4. Less Risk, More Speed -The New Blueprint For Bioconjugate Development 4/15/2026

    A fireside chat on how integrated development models reduce risk and accelerate bioconjugate timelines from discovery through GMP manufacturing.

  5. Formulating The Future: A Practical Guide To Nucleic Acid Therapeutics 4/14/2026

    An expert-led webinar exploring nucleic acid therapeutic modalities, delivery systems, formulation challenges, and real-world case studies shaping drug product development.

  6. ADC Payloader-Linker CMC Process Development Strategy 4/13/2026

    Shows how payload‑linker CMC planning differs from clinical to commercial, what drives route and RSM decisions, and how QC shifts from release testing to CQA‑linked specs, illustrated with IND vs NDA.

  7. HPAPIS Production: "Where Micrograms Matters" 4/13/2026

    In HPAPI manufacturing, micrograms make a difference. Risk‑based containment, smart facility design, and exposure limits safeguard people, product, and performance.

  8. From Bench To Approval: Smart IVBE Strategies For Complex Drugs 4/10/2026

    In vitro bioequivalence can replace clinical studies for complex products when well designed. Clinically relevant, risk-based methods under realistic conditions show site-of-action equivalence.

  9. From Fermentation To Vaccination 4/8/2026

    Non-animal-origin squalene is gaining momentum in vaccine adjuvants. See how fermentation-derived squalene delivers comparable performance, strong stability, and regulatory alignment.

  10. From Clinical To Commercial: Introducing Devices Earlier To Streamline The DDC Journey 4/8/2026

    Uncover how early device strategy and integrated planning can streamline development, reduce risk, and accelerate your path to commercial success.